FDAnews Announces -- Pharmacy Compounding Regulation: A Fresh Look at Guidance, Compliance, Enforcement Webinar, July 11, 2019, 2019
FALLS CHURCH, Va., June 27, 2019 /PRNewswire-PRWeb/ -- Pharmacy Compounding Regulation A Fresh Look at Guidance, Compliance, Enforcement **An FDAnews Webinar** Thursday, July 11, 2019 · 1:30 p.m. - 3:00 p.m. EDT https://www.fdanews.com/pharmacycompoundingregulation0719
FDA scrutiny on compounding pharmacies is increasing
Recent example: Triad Rx, where the agency found 11 adulteration violations including visibly dirty surfaces and non-sterile cleaning methods in ISO 5 areas.
Last October Karla Palmer Esq. delivered a hard-hitting webinar on the state of compounding regulation. It's time for an update.
Tune in Thursday, July 11, when Ms. Palmer, among the Washington FDA bar's foremost experts on compounding, explains the 2018 Compounding Priorities Plan and shows what's behind the accelerating enforcement. Attendees will discover:
Secs. 503A and 503B: How these sections of the 2013 Drug Quality and Security Act (the "Compounding Quality Act") affect compounding pharmacies and outsourcing facilities
Draft and final guidances: Changes brought about in draft and final guidances to Secs. 503A and 503B
Warning letters and 483s: Understand what enforcement actions FDA has taken against compounders to date and what could lie down the road
Compounding inspections: What the FDA is looking for right now
Role of the states: Interplay between FDA and state regulation of outsourcing facilities and compounding pharmacies
There's a new director of the Division of Compounded Drugs. This webinar is a must-attend even if one caught Ms. Palmer's first presentation last October.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Pharmacy Compounding Regulation A Fresh Look at Guidance, Compliance, Enforcement **An FDAnews Webinar** Thursday, July 11, 2019 · 1:30 p.m. - 3:00 p.m. EDT https://www.fdanews.com/pharmacycompoundingregulation0719
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
TÜV Rheinland, a leading certification, testing and inspection company, presented its annual report in which it highlighted substantial investment in its strategic growth in 2023. The globally active testing group took over ten companies in Germany,...
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
AnalytixInsight Inc. ("AnalytixInsight", or the "Company") announced today an anticipated delay in the filing of its audited financial statements for the year ended December 31, 2023, its related Management's Discussion and Analysis and the...
Lamborghini Charlotte, the premier destination for automotive enthusiasts and luxury car aficionados, is thrilled to announce the availability of an exclusive collection of used Lamborghini vehicles at its esteemed dealership located in Charlotte,...
Stratos, a VC firm focused on early-stage crypto projects with close to $500M assets under management, shares its Q1 gains showcasing a 137% return (109% net) for their liquid token fund and a total net value of over 25x for their second early-stage...
Lumin Digital (Lumin), a leading fintech company specializing in digital banking solutions, continues to strengthen its senior leadership team with the appointment of Lisa Sutton as chief talent officer (CTO). Sutton's addition underscores Lumin's...